Cargando…

Efficacy of conversion therapy on initially unresectable locally advanced rectal cancer

Background and purpose: Research on the efficacy of conversion therapy for initially unresectable mid-low rectal cancer (IURC) remained limited. This study aimed to assess the efficacy and safety of the conversion regimen for IURC and analyze the long-term outcomes of these patients. Methods: We ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tianyu, Chang, Wenju, Wang, Jian, Ren, Li, Wei, Ye, Zhang, Xian, Chen, Yijiao, Tang, Wentao, Wang, Mingliang, Zeng, Zhaochong, Xu, Jianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176423/ https://www.ncbi.nlm.nih.gov/pubmed/34093842 http://dx.doi.org/10.7150/jca.53824

Ejemplares similares

The Combination of Neoadjuvant Therapy and Surgical Resection: A Safe and Effective Treatment for Rectal Gastrointestinal Stromal Tumors
por: Liu, Yu, et al.
Publicado: (2021)

Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis
por: Jian, Mi, et al.
Publicado: (2019)

Short-term and long-term outcomes of robotic rectal surgery—from the real word data of 1145 consecutive cases in China
por: Chang, Wenju, et al.
Publicado: (2019)

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
por: Luo, Laihui, et al.
Publicado: (2022)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
por: Sun, Hui-Chuan, et al.
Publicado: (2021)

Evaluation of Efficacy and Tolerance of Radical Radiotherapy and Radiochemotherapy in Treatment of Locally Advanced, Unresectable Rectal Cancer
por: Kraszkiewicz, M., et al.
Publicado: (2022)

Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression
por: Liu, Yu, et al.
Publicado: (2022)

Anatomical Resection Improves Disease-Free Survival After Lung Metastasectomy of Colorectal Cancer
por: Liu, Tianyu, et al.
Publicado: (2021)

A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases
por: Jian, Mi, et al.
Publicado: (2020)

Conversion surgery for initially unresectable extrahepatic biliary tract cancer
por: Oh, Moon Young, et al.
Publicado: (2021)

The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer
por: Liu, Tianyu, et al.
Publicado: (2022)

Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report
por: Fujishiro, Takeshi, et al.
Publicado: (2018)

Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro)
por: Huang, Shujie, et al.
Publicado: (2022)

Treatment effect of conversion therapy and its correlation with VEGF expression in unresectable rectal cancer with liver metastasis
por: Hou, Ge, et al.
Publicado: (2018)

Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma
por: Chen, Kang, et al.
Publicado: (2022)

Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study
por: Chang, Wenju, et al.
Publicado: (2023)

Conversion surgery with gemcitabine plus nab-paclitaxel for locally advanced unresectable pancreatic cancer: A case report
por: Okura, Ryosuke, et al.
Publicado: (2018)

A Case of Unresectable Rectal Necrosis
por: Nassif, Mohammed, et al.
Publicado: (2011)

Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC
por: Zhao, Qianqian, et al.
Publicado: (2019)

Splenic artery transposition for hepatic arterial reconstruction in conversion surgery of an initially unresectable, locally advanced pancreatic cancer after gemcitabine/nab-paclitaxel: A case report
por: Tanaka, Hideharu, et al.
Publicado: (2020)

Long-term Results of Conversion Therapy for Initially Unresectable Gastric Cancer: Analysis of 122 Patients at the National Cancer Center in China
por: Wang, Tongbo, et al.
Publicado: (2019)

Induction Strategy for Locally Advanced Thymoma
por: Zhang, Yang, et al.
Publicado: (2021)

Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX)
por: Wang, Yan, et al.
Publicado: (2016)

The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience
por: Cai, Xin, et al.
Publicado: (2020)

Locally Advanced, Unresectable Squamous Cell Carcinoma of the Gallbladder
por: Weatherall, Timothy J., et al.
Publicado: (2015)

Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma
por: Satoi, Sohei, et al.
Publicado: (2019)

Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer
por: Nakamura, Ikuo, et al.
Publicado: (2023)

Definitive carbon ion re-irradiation with pencil beam scanning in the treatment of unresectable locally recurrent rectal cancer
por: Cai, Xin, et al.
Publicado: (2023)

Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study
por: Zhang, Jinliang, et al.
Publicado: (2021)

Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
por: Ye, Zaisheng, et al.
Publicado: (2021)

Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome
por: Niu, Shao-Qing, et al.
Publicado: (2021)

Short-course radiotherapy and chemotherapy for conversion surgery in patients with unresectable metastatic rectal cancer: a preliminary case series study
por: Jeon, Youngbae, et al.
Publicado: (2021)

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
por: Li, Binkui, et al.
Publicado: (2021)

A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma
por: Gan, Leijuan, et al.
Publicado: (2023)

Optimal Initial Time Point of Local Radiotherapy for Unresectable Lung Adenocarcinoma: A Retrospective Analysis on Overall Arrangement of Local Radiotherapy in Advanced Lung Adenocarcinoma
por: Li, Xinge, et al.
Publicado: (2022)

Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
por: Zhang, Ze-Feng, et al.
Publicado: (2018)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer
por: Zhang, Caihua, et al.
Publicado: (2012)

Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study
por: Chang, Hui, et al.
Publicado: (2018)

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial
por: Zhang, Wenwen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u3fv97hglu5369ermlsdv7cagb